Completely agree. To see it being used in extremely complex scenarios with immunosuppressed patients battling severe infection and having great wound recovery outcomes is phenomenal. Throw a biological into that mess and you would have a soup for infection to thrive in. This is groundbreaking.
PNV Media Thread, page-897
-
- There are more pages in this discussion • 2,340 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.31 |
Change
0.010(0.43%) |
Mkt cap ! $1.594B | |||
| Open | High | Low | Value | Volume |
| $2.31 | $2.43 | $2.31 | $5.748M | 2.449M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10174 | $2.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.33 | 9961 | 2 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |